-
-
-
-
-
-
-
Bio-Rad Labs (BIO) Tops Q1 EPS by 5c, Beats on Revenue; Offers Guidance
-
-
-
-
-
-
-
Bio-Rad Labs (BIO) Tops Q2 EPS by 88c; updates outlook
-
-
-
-
-
-
-
OncoCyte (OCX) Reports Successful 2024; Sets Stage for 2025 Catalysts
-
-
-
-
-
-
-
Palantir, Dell to join S&P 500
-
-
-
-
479,045 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


